Carsten Bindslev-Jensen: Clinical Trials

2 trials sponsored by Carsten Bindslev-Jensen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Terminated 1

Follow Carsten Bindslev-Jensen: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Behandling af Boern Med Foedevareallergi Med Omalizumab (Xolair)
Omalizumab, Placebo - Food Allergy
Phase 4CompletedCarsten Bindslev-Jensen202019-11-012023-12-05
Protection From Food Induced Anaphylaxis by Reducing the Serum Level of Specific IgE (Protana).
Omalizumab Injection - Food Allergy
Phase 4TerminatedCarsten Bindslev-Jensen72019-07-012023-12-11

Conditions studied

Food Hypersensitivity (2)  ·  Anaphylaxis (1)

Interventions

Omalizumab (2)

Countries

Denmark (2)

Top investigators

Charlotte G. Moertz, ProfMDPhd (1)  ·  Susanne Halken, Prof DM MD (1)

NIH funding

2017 (1)